Group One Trading’s Jasper Therapeutics JSPR Stock Holding History

Group One Trading’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,200	Closed	-$17.1K	–	8652
2025 Q3	$17.1K	Sell	7,200 -2,500	-26%	-$7.58K	﹤0.01%	6815
2025 Q2	$53.8K	Buy	9,700 +9,200	+1,840%	+$45.3K	﹤0.01%	5521
2025 Q1	$2.15K	Buy	+500	New	+$3.33K	﹤0.01%	6982
2023 Q4	–	Sell	-6,160	Closed	-$43.1K	–	7781
2023 Q3	$43.1K	Buy	6,160 +6,040	+5,033%	+$73.7K	﹤0.01%	5242
2023 Q2	$1.64K	Sell	120 -770	-87%	-$11.4K	﹤0.01%	7141
2023 Q1	$16.1K	Buy	+890	New	+$16.5K	﹤0.01%	5654
2022 Q4	–	Sell	-600	Closed	-$5K	–	7665
2022 Q3	$5K	Sell	600 -600	-50%	-$11K	﹤0.01%	6831
2022 Q2	$23K	Buy	+1,200	New	+$34.2K	﹤0.01%	6178

Other funds holding JSPR

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's JSPR Position: Q2 2026 in Review

Group One Trading increased its Jasper Therapeutics (JSPR) stake by 2,152% in Q2 2026, buying an estimated $14.3K and bringing the position to 19,930 shares worth $8.39K. The position accounts for ﹤0.01% of the portfolio, ranked #6504.

Group One Trading first reported a position in JSPR in Q2 2022 and has held it in 9 quarters since. The position peaked at $41.8K in Q3 2025. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

Group One Trading held 19,930 shares of Jasper Therapeutics worth $8.39K as of Q2 2026.
Group One Trading bought 19,045 Jasper Therapeutics shares in Q2 2026, an estimated $14.3K.
Jasper Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6504 holding.
Group One Trading first reported a position in Jasper Therapeutics in Q2 2022 and has held it in 9 quarters since.
Group One Trading's Jasper Therapeutics position peaked at $41.8K in Q3 2025.
45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.